Sterile Injectable Drugs Market

Table of Content

1. Executive Summary

2. Market Introduction

    2.1. Market Definition

    2.2. Market Taxonomy

3. Global Sterile Injectable Drugs Market Analysis Scenario

    3.1. Market Size (US$ Bn) and Forecast

        3.1.1. Market Size and Y-o-Y Growth

        3.1.2. Absolute $ Opportunity

    3.2. Market Overview

        3.2.1. Value Chain

4. Market Dynamics

    4.1. Macro-economic Factors

    4.2. Drivers

        4.2.1. Supply Side

        4.2.2. Demand Side

    4.3. Restraints

    4.4. Opportunity

    4.5. Forecast Factors – Relevance and Impact

    4.6. Patent Expiries

5. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Molecules

    5.1. Introduction

    5.2. Basis Point Share (BPS) Analysis By Molecules Type

    5.3. Y-o-Y Growth Projections By Molecules Type

    5.4. Market Value Forecast By Molecules, 2016–2024

        5.4.1. Large Molecules

        5.4.2. Small Molecules

    5.5. Market Attractiveness By Molecules

6. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Drugs

    6.1. Introduction

    6.2. Basis Point Share (BPS) Analysis By Drugs

    6.3. Y-o-Y Growth Projections By Drugs

    6.4. Market Value Forecast By Drugs , 2016–2024

        6.4.1. Monoclonal Antibodies (Mabs)

        6.4.2. Cytokines

        6.4.3. Insulin

        6.4.4. Peptide Hormones

        6.4.5. Vaccines

        6.4.6. Immunoglobulins

        6.4.7. Blood Factors

        6.4.8. Peptide Antibiotics

        6.4.9. Others

    6.5. Market Attractiveness By Drugs

7. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Application

    7.1. Introduction

    7.2. Basis Point Share (BPS) Analysis By Application

    7.3. Y-o-Y Growth Projections By Application

    7.4. Market Value Forecast By Application, 2016–2024

        7.4.1. Cancer

        7.4.2. Diabetes

        7.4.3. Cardiovascular Diseases

        7.4.4. Musculoskeletal

        7.4.5. CNS

        7.4.6. Infections

        7.4.7. Others

    7.5. Market Attractiveness By Application

8. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Route of Administration

    8.1. Introduction

    8.2. Basis Point Share (BPS) Analysis By Route of Administration

    8.3. Y-o-Y Growth Projections By Route of Administration

    8.4. Market Value Forecast By Route of Administration, 2016–2024

        8.4.1. Intravenous (IV)

        8.4.2. Intramuscular (IM)

        8.4.3. Subcutaneous (SC)

        8.4.4. Others

    8.5. Market Attractiveness By Route of Administration

9. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Distribution Channel

    9.1. Introduction

    9.2. Basis Point Share (BPS) Analysis By Distribution Channel

    9.3. Y-o-Y Growth Projections By Distribution Channel

    9.4. Market Value Forecast By Distribution Channel , 2019–2024

        9.4.1. Hospitals Pharmacies

        9.4.2. Retail Pharmacies

        9.4.3. Online Pharmacies

    9.5. Market Attractiveness By Distribution Channel

10. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Region

    10.1. Basis Point Share (BPS) Analysis By Region

    10.2. Y-o-Y Growth Projections By Region

    10.3. Market Value Forecast By Region

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. APEJ

        10.3.5. MEA

    10.4. Market Attractiveness By Region

11. North America Sterile Injectable Drugs Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Basis Point Share (BPS) Analysis By Country

        11.1.2. Y-o-Y Growth Projections By Country

    11.2. Market Value Forecast By Molecules, 2016–2024

        11.2.1. Large Molecules

        11.2.2. Small Molecules

    11.3. Market Value Forecast By Distribution Channel , 2016–2024

        11.3.1. Hospitals Pharmacies

        11.3.2. Retail Pharmacies

        11.3.3. Online Pharmacies

    11.4. Market Value Forecast By Drugs , 2016–2024

        11.4.1. Monoclonal Antibodies (Mabs)

        11.4.2. Cytokines

        11.4.3. Insulin

        11.4.4. Peptide Hormones

        11.4.5. Vaccines

        11.4.6. Immunoglobulins

        11.4.7. Blood Factors

        11.4.8. Peptide Antibiotics

        11.4.9. Others

    11.5. Market Value Forecast By Application, 2016–2024

        11.5.1. Cancer

        11.5.2. Diabetes

        11.5.3. Cardiovascular Diseases

        11.5.4. Musculoskeletal

        11.5.5. CNS

        11.5.6. Infections

        11.5.7. Others

    11.6. Market Value Forecast By Route of Administration, 2016–2024

        11.6.1. Intravenous (IV)

        11.6.2. Intramuscular (IM)

        11.6.3. Subcutaneous (SC)

        11.6.4. Others

    11.7. Market Value Forecast By Country, 2016–2024

        11.7.1. US

        11.7.2. Canada

    11.8. Market Attractiveness Analysis

        11.8.1. By Molecules

        11.8.2. By Distribution Channel

        11.8.3. By Drugs

        11.8.4. By Application

        11.8.5. By Route of Administration

        11.8.6. By Country

    11.9. Prominent Trends

12. Latin America Sterile Injectable Drugs Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Basis Point Share (BPS) Analysis By Country

        12.1.2. Y-o-Y Growth Projections By Country

    12.2. Market Value Forecast By Molecules, 2016–2024

        12.2.1. Large Molecules

        12.2.2. Small Molecules

    12.3. Market Value Forecast By Distribution Channel , 2016–2024

        12.3.1. Hospitals Pharmacies

        12.3.2. Retail Pharmacies

        12.3.3. Online Pharmacies

    12.4. Market Value Forecast By Drugs , 2016–2024

        12.4.1. Monoclonal Antibodies (Mabs)

        12.4.2. Cytokines

        12.4.3. Insulin

        12.4.4. Peptide Hormones

        12.4.5. Vaccines

        12.4.6. Immunoglobulins

        12.4.7. Blood Factors

        12.4.8. Peptide Antibiotics

        12.4.9. Others

    12.5. Market Value Forecast By Application, 2016–2024

        12.5.1. Cancer

        12.5.2. Diabetes

        12.5.3. Cardiovascular Diseases

        12.5.4. Musculoskeletal

        12.5.5. CNS

        12.5.6. Infections

        12.5.7. Others

    12.6. Market Value Forecast By Route of Administration, 2016–2024

        12.6.1. Intravenous (IV)

        12.6.2. Intramuscular (IM)

        12.6.3. Subcutaneous (SC)

        12.6.4. Others

    12.7. Market Value Forecast By Country, 2016–2024

        12.7.1. Brazil

        12.7.2. Mexico

        12.7.3. Rest of Latin America

    12.8. Market Attractiveness Analysis

        12.8.1. By Molecules

        12.8.2. By Distribution Channel

        12.8.3. By Drugs

        12.8.4. By Application

        12.8.5. By Route of Administration

        12.8.6. By Country

    12.9. Prominent Trends

13. Europe Sterile Injectable Drugs Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Basis Point Share (BPS) Analysis By Country

        13.1.2. Y-o-Y Growth Projections By Country

    13.2. Market Value Forecast By Molecules, 2016–2024

        13.2.1. Large Molecules

        13.2.2. Small Molecules

    13.3. Market Value Forecast By Distribution Channel , 2016–2024

        13.3.1. Hospitals Pharmacies

        13.3.2. Retail Pharmacies

        13.3.3. Online Pharmacies

    13.4. Market Value Forecast By Drugs , 2016–2024

        13.4.1. Monoclonal Antibodies (Mabs)

        13.4.2. Cytokines

        13.4.3. Insulin

        13.4.4. Peptide Hormones

        13.4.5. Vaccines

        13.4.6. Immunoglobulins

        13.4.7. Blood Factors

        13.4.8. Peptide Antibiotics

        13.4.9. Others

    13.5. Market Value Forecast By Application, 2016–2024

        13.5.1. Cancer

        13.5.2. Diabetes

        13.5.3. Cardiovascular Diseases

        13.5.4. Musculoskeletal

        13.5.5. CNS

        13.5.6. Infections

        13.5.7. Others

    13.6. Market Value Forecast By Route of Administration, 2016–2024

        13.6.1. Intravenous (IV)

        13.6.2. Intramuscular (IM)

        13.6.3. Subcutaneous (SC)

        13.6.4. Others

    13.7. Market Value Forecast By Country, 2016–2024

        13.7.1. UK

        13.7.2. France

        13.7.3. Germany

        13.7.4. Italy

        13.7.5. Spain

        13.7.6. Russia

        13.7.7. Rest of Europe

    13.8. Market Attractiveness Analysis

        13.8.1. By Molecules

        13.8.2. By Distribution Channel

        13.8.3. By Drugs

        13.8.4. By Application

        13.8.5. By Route of Administration

        13.8.6. By Country

    13.9. Prominent Trends

14. APEJ Sterile Injectable Drugs Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Basis Point Share (BPS) Analysis By Country

        14.1.2. Y-o-Y Growth Projections By Country

    14.2. Market Value Forecast By Molecules, 2016–2024

        14.2.1. Large Molecules

        14.2.2. Small Molecules

    14.3. Market Value Forecast By Distribution Channel , 2016–2024

        14.3.1. Hospitals Pharmacies

        14.3.2. Retail Pharmacies

        14.3.3. Online Pharmacies

    14.4. Market Value Forecast By Drugs , 2016–2024

        14.4.1. Monoclonal Antibodies (Mabs)

        14.4.2. Cytokines

        14.4.3. Insulin

        14.4.4. Peptide Hormones

        14.4.5. Vaccines

        14.4.6. Immunoglobulins

        14.4.7. Blood Factors

        14.4.8. Peptide Antibiotics

        14.4.9. Others

    14.5. Market Value Forecast By Application, 2016–2024

        14.5.1. Cancer

        14.5.2. Diabetes

        14.5.3. Cardiovascular Diseases

        14.5.4. Musculoskeletal

        14.5.5. CNS

        14.5.6. Infections

        14.5.7. Others

    14.6. Market Value Forecast By Route of Administration, 2016–2024

        14.6.1. Intravenous (IV)

        14.6.2. Intramuscular (IM)

        14.6.3. Subcutaneous (SC)

        14.6.4. Others

    14.7. Market Value Forecast By Country, 2016–2024

        14.7.1. Japan

        14.7.2. China

        14.7.3. India

        14.7.4. Australia & New Zealand

        14.7.5. ASEAN

        14.7.6. Rest of APAC

    14.8. Market Attractiveness Analysis

        14.8.1. By Molecules

        14.8.2. By Distribution Channel

        14.8.3. By Drugs

        14.8.4. By Application

        14.8.5. By Route of Administration

        14.8.6. By Country

    14.9. Prominent Trends

15. MEA Sterile Injectable Drugs Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Basis Point Share (BPS) Analysis By Country

        15.1.2. Y-o-Y Growth Projections By Country

    15.2. Market Value Forecast By Molecules, 2016–2024

        15.2.1. Large Molecules

        15.2.2. Small Molecules

    15.3. Market Value Forecast By Distribution Channel , 2016–2024

        15.3.1. Hospitals Pharmacies

        15.3.2. Retail Pharmacies

        15.3.3. Online Pharmacies

    15.4. Market Value Forecast By Drugs , 2016–2024

        15.4.1. Monoclonal Antibodies (Mabs)

        15.4.2. Cytokines

        15.4.3. Insulin

        15.4.4. Peptide Hormones

        15.4.5. Vaccines

        15.4.6. Immunoglobulins

        15.4.7. Blood Factors

        15.4.8. Peptide Antibiotics

        15.4.9. Others

    15.5. Market Value Forecast By Application, 2016–2024

        15.5.1. Cancer

        15.5.2. Diabetes

        15.5.3. Cardiovascular Diseases

        15.5.4. Musculoskeletal

        15.5.5. CNS

        15.5.6. Infections

        15.5.7. Others

    15.6. Market Value Forecast By Route of Administration, 2016–2024

        15.6.1. Intravenous (IV)

        15.6.2. Intramuscular (IM)

        15.6.3. Subcutaneous (SC)

        15.6.4. Others

    15.7. Market Value Forecast By Country, 2016–2024

        15.7.1. GCC Countries

        15.7.2. South Africa

        15.7.3. North Africa

        15.7.4. Rest of MEA

    15.8. Market Attractiveness Analysis

        15.8.1. By Molecules

        15.8.2. By Distribution Channel

        15.8.3. By Drugs

        15.8.4. By Application

        15.8.5. By Route of Administration

        15.8.6. By Country

    15.9. Prominent Trends

16. Competition Landscape

    16.1. Competition Dashboard

    16.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

        16.2.1. Baxter International Inc.

        16.2.2. Sanofi

        16.2.3. Pfizer Inc.

        16.2.4. GlaxoSmithKline plc.

        16.2.5. AstraZeneca

        16.2.6. GILEAD SCIENCES, INC.

        16.2.7. Merck & Co., Inc.

        16.2.8. Novartis AG

        16.2.9. Johnson & Johnson Services, Inc.

        16.2.10. Nova Nordisk A/S

17. Assumptions and Acronyms Used

18. Research Methodology

List Of Table

List of Tables

Table 01: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015–2024

Table 02: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015–2024

Table 03: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015–2024

Table 04: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015–2024

Table 05: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015–2024

Table 06: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Region, 2015–2024

Table 07: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Country, 2015–2024

Table 08: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015–2024

Table 09: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015–2024

Table 10: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015–2024

Table 11: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015–2024

Table 12: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel,

Table 13: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Country, 2015–2024

Table 14: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015–2024

Table 15: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015–2024

Table 16: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015–2024

Table 17: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015–2024

Table 18: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel,

Table 19: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Country, 2015–2024

Table 20: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015–2024

Table 21: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015–2024

Table 22: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015–2024

Table 23: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015–2024

Table 24: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015–2024

Table 25: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Country, 2015–2024

Table 26: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015–2024

Table 27: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015–2024

Table 28: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015–2024

Table 29: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015–2024

Table 30: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015–2024

Table 31: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Country, 2015–2024

Table 32: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015–2024

Table 33: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015–2024

Table 34: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015–2024

Table 35: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015–2024

Table 36: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015–2024

- List Of Chart -

List of Figures

Figure 01: Global Sterile Injectable Drugs Market – Scenario Forecast, 2016–2024 (US$ Bn)

Figure 02 : Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 03 : Global Sterile Injectable Drugs Market Absolute $ Opportunity, 2016–2024

Figure 04 : Global Sterile Injectable Drugs Market Share Analysis (%) By Molecule Type, 2016 & 2024

Figure 05 : Global Sterile Injectable Drugs Y-o-Y growth (%) By Molecule Type, 2016–2024

Figure 06: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Small Molecules Segment, 2015–2024

Figure 07: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Small Molecules Segment, 2016–2024

Figure 08: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Large Molecules Segment, 2015–2024

Figure 09: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Large Molecules Segment, 2016–2024

Figure 10: Global Sterile Injectable Drugs Market Attractiveness Analysis By Molecule Type, 2016–2024

Figure 11: Global Sterile Injectable Drugs Market Share Analysis (%) By Drug Type, 2016 & 2024

Figure 12: Global Sterile Injectable Drugs Y-o-Y growth (%) By Drug Type, 2016–2024

Figure 13: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Monoclonal Antibodies (mAbs) Segment, 2015–2024

Figure 14: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Monoclonal Antibodies (mAbs) Segment, 2016–2024

Figure 15: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Cytokines Segment, 2015–2024

Figure 16: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Cytokines Segment, 2016–2024

Figure 17: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Insulin Segment, 2015–2024

Figure 18: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Insulin Segment, 2016–2024

Figure 19: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Peptide Hormones Segment, 2015–2024

Figure 20: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Peptide Hormones Segment, 2016–2024

Figure 21: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) Vaccines Segment, 2015–2024

Figure 22: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Vaccines Segment, 2016–2024

Figure 23: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Immunoglobulins Segment, 2015–2024

Figure 24: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Immunoglobulins Segment, 2016–2024

Figure 25: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Blood Factors Segment, 2015–2024

Figure 26: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Blood Factors Segment, 2016–2024

Figure 27: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Peptide Antibiotics Segment,2015–2024

Figure 28: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Peptide Antibiotics Segment, 2016–2024

Figure 29: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Others Segment, 2015–2024

Figure 30: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Others Segment, 2016–2024

Figure 31: Global Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016–2024

Figure 32: Global Sterile Injectable Drugs Market Share Analysis (%) By Application, 2016 & 2024

Figure 33: Global Sterile Injectable Drugs Y-o-Y growth (%) By Application, 2016–2024

Figure 34: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Cancer Segment, 2015–2024

Figure 35: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Cancer Segment, 2016–2024

Figure 36: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Diabetes Segment, 2015–2024

Figure 37: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Diabetes Segment, 2016–2024

Figure 38: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Cardiovascular Diseases Segment,2015–2024

Figure 39: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Cardiovascular Diseases Segment, 2016–2024

Figure 40: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Musculoskeletal Segment,2015–2024

Figure 41: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Musculoskeletal Segment, 2016–2024

Figure 42: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By CNS Segment, 2015–2024

Figure 43: Global Sterile Injectable Drugs Market Absolute $ Opportunity By CNS Segment, 2016–2024

Figure 44: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Infections Segment, 2015–2024

Figure 45: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Infections Segment, 2016–2024

Figure 46: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Others Segment, 2015–2024

Figure 47: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Others Segment, 2016–2024

Figure 48: Global Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016–2024

Figure 49: Global Sterile Injectable Drugs Market Share Analysis (%) By Routes of Administration, 2016 & 2024

Figure 50: Global Sterile Injectable Drugs Y-o-Y growth (%) By Routes of Administration, 2016–2024

Figure 51: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Intravenous (IV) Segment,2015–2024

Figure 52: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Intravenous (IV) Segment, 2016–2024

Figure 53: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Intramuscular (IM) Segment, 2015–2024

Figure 54: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Intramuscular (IM) Segment, 2016–2024

Figure 55: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Subcutaneous (SC) Segment, 2015–2024

Figure 56: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Subcutaneous (SC) Segment, 2016–2024

Figure 57: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Others Segment, 2015–2024

Figure 58: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Others Segment, 2016–2024

Figure 59: Global Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016–2024

Figure 60: Global Sterile Injectable Drugs Market Share Analysis (%) By Distribution Channel, 2016 & 2024

Figure 61: Global Sterile Injectable Drugs Y-o-Y growth (%) By Distribution Channel, 2016–2024

Figure 62: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Hospital Pharmacies Segment, 2015–2024

Figure 63: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Hospital Pharmacies Segment, 2016–2024

Figure 64: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Retail Pharmacies Segment, 2015–2024

Figure 65: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Retail Pharmacies Segment, 2016–2024

Figure 66: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Online Pharmacies Segment, 2015–2024

Figure 67: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Online Pharmacies Segment, 2016–2024

Figure 68: Global Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016–2024

Figure 69: Global Sterile Injectable Drugs Market Share Analysis (%) By Region, 2016 & 2024

Figure 70: Global Sterile Injectable Drugs Y-o-Y growth (%) By Region, 2016–2024

Figure 71: North America Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 72: North America Sterile Injectable Drugs Market Absolute $ Opportunity, 2016–2024

Figure 73: Latin America Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 74: Latin America Sterile Injectable Drugs Market Absolute $ Opportunity, 2016–2024

Figure 75: Europe Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 76: Europe Sterile Injectable Drugs Market Absolute $ Opportunity, 2016–2024

Figure 77: APAC Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 78: APAC Sterile Injectable Drugs Market Absolute $ Opportunity, 2016–2024

Figure 79: MEA Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 80: MEA Sterile Injectable Drugs Market Absolute $ Opportunity, 2016–2024

Figure 81: Global Sterile Injectable Drugs Market Attractiveness Analysis By Region, 2016–2024

Figure 82: North America Sterile Injectable Drugs Market Share Analysis (%) By Country, 2016 & 2024

Figure 83: North America Sterile Injectable Drugs Y-o-Y growth (%) By Country, 2016–2024

Figure 84: U.S. Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 85: U.S. Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024

Figure 86: Canada Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 87: Canada Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn) 2016–2024

Figure 88: North America Sterile Injectable Drugs Market Attractiveness Analysis By Country, 2016–2024

Figure 89: North America Sterile Injectable Drugs Market Attractiveness Analysis By Molecule type, 2016–2024

Figure 90: North America Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016–2024

Figure 91: North America Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016–2024

Figure 92: North America Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016–2024

Figure 93: North America Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016–2024

Figure 94: Latin America Sterile Injectable Drugs Market Share Analysis (%) By Country, 2016 & 2024

Figure 95: Latin America Sterile Injectable Drugs Y-o-Y growth (%) By Country, 2016–2024

Figure 96: Brazil Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 97: Brazil Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024

Figure 98: Mexico Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 99: Mexico Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024

Figure 100: Rest of Latin America Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 101: Rest of Latin America Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024

Figure 102: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Country, 2016–2024

Figure 103: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Molecule type, 2016–2024

Figure 104: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016–2024

Figure 105: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016–2024

Figure 106: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016–2024

Figure 107: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016–2024

Figure 108: Europe Sterile Injectable Drugs Market Share Analysis (%) By Country, 2016 & 2024

Figure 109: Europe Sterile Injectable Drugs Y-o-Y growth (%) By Country, 2016–2024

Figure 110: Germany Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 111: Germany Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024

Figure 112: France Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 113: France Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024

Figure 114: Russia Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 115: Russia Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024

Figure 116: Italy Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 117: Italy Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024

Figure 118: Spain Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 119: Spain Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024

Figure 120: U.K. Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 121: U.K. Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024

Figure 122: Rest of Europe Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 123: Rest of Europe Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024

Figure 124: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Country, 2016–2024

Figure 125: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Molecule type, 2016–2024

Figure 126: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016–2024

Figure 127: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016–2024

Figure 128: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016–2024

Figure 129: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016–2024

Figure 130: APAC Sterile Injectable Drugs Market Share Analysis (%) By Country, 2016 & 2024

Figure 131: APAC Sterile Injectable Drugs Y-o-Y growth (%) By Country, 2016–2024

Figure 132: China Sterile Injectable Drugs Market Value

Figure 133: China Sterile Injectable Drugs Market Absolute $ Opportunity (US$), 2016–2024

Figure 134: India Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 135: India Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024

Figure 136: Japan Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 137: Japan Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024

Figure 138: Australia & New Zealand Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 139: Australia & New Zealand Sterile Injectable Drugs Market Absolute $ Opportunity, 2016–2024

Figure 140: ASEAN Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 141: ASEAN Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024

Figure 142: Rest of APAC Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 143: Rest of APAC Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024

Figure 144: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Country, 2016–2024

Figure 145: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Molecule type, 2016–2024

Figure 146: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016–2024

Figure 147: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016–2024

Figure 148: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016–2024

Figure 149: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016–2024

Figure 150: MEA Sterile Injectable Drugs Market Share Analysis (%) By Country, 2016 & 2024

Figure 151: MEA Sterile Injectable Drugs Y-o-Y growth (%) By Country, 2016–2024

Figure 152: GCC Countries Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 153: GCC Countries Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024

Figure 154: South Africa Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 155: South Africa Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn) 2016–2024

Figure 156: North Africa Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 157: North Africa Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn) 2016–2024

Figure 158: Rest of MEA Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024

Figure 159: Rest of MEA Sterile Injectable Drugs Market Absolute $ Opportunity (US$), 2016–2024

Figure 160: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Country, 2016–2024

Figure 161: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Molecule type, 2016–2024

Figure 162: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016–2024

Figure 163: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016–2024

Figure 164: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016–2024

Figure 165: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016–2024